We are live on
!
Find out more
RMA
Roffman Miller Associates Portfolio holdings
AUM
$1.91B
1-Year Est. Return
28.29%
This Fund
S&P 500
This Quarter
Est. Return
+4.41%
1 Year Est. Return
+28.29%
3 Year Est. Return
+68.87%
5 Year Est. Return
+84.92%
10 Year Est. Return
+298.67%
AUM
$583M
AUM Growth
+$36.8M
(+6.7%)
Cap. Flow
+$15.8M
Cap. Flow
% of AUM
2.71%
Top 10 Holdings %
Top 10 Hldgs %
31.51%
Holding
66
New
2
Increased
44
Reduced
18
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$7.17M |
| 2 |
Kraft Heinz
KHC
|
+$1.48M |
| 3 |
GE Aerospace
GE
|
+$1.04M |
| 4 |
Johnson & Johnson
JNJ
|
+$990K |
| 5 |
Texas Instruments
TXN
|
+$936K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bath & Body Works
BBWI
|
+$6.11M |
| 2 |
TIF
Tiffany & Co.
TIF
|
+$3.29M |
| 3 |
McCormick & Company Non-Voting
MKC
|
+$817K |
| 4 |
TechnipFMC
FTI
|
+$387K |
| 5 |
DD
Du Pont De Nemours E I
DD
|
+$258K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 16.33% |
| 2 | Consumer Staples | 15.41% |
| 3 | Consumer Discretionary | 15.04% |
| 4 | Technology | 14.57% |
| 5 | Healthcare | 10.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Occidental Petroleum
OXY
$56.8B
| $1.86M | 0.32% |
27,130
+1,510
| +6% | +$101K |
|
52
Southern Company
SO
$109B
| $792K | 0.14% |
15,307
-909
| -6% | -$44.3K |
|
53
Berkshire Hathaway Class B
BRK.B
$1.1T
| $782K | 0.13% |
5,513
-88
| -2% | -$11.7K |
|
54
Bristol-Myers Squibb
BMY
$133B
| $645K | 0.11% |
10,103
-792
| -7% | -$49.9K |
|
|
TIF
55
DELISTED
Tiffany & Co.
TIF
| $615K | 0.11% |
8,382
-49,012
| -85% | -$3.29M |
|
56
Cisco
CSCO
$457B
| $595K | 0.1% |
20,888
+891
| +4% | +$22.9K |
|
57
Schwab US TIPS ETF
SCHP
$16.2B
| $579K | 0.1% |
20,836
-1,680
| -7% | -$45.4K |
|
58
Oracle
ORCL
$374B
| $454K | 0.08% |
11,103
-831
| -7% | -$30.8K |
|
59
Essential Utilities
WTRG
$11.3B
| $449K | 0.08% |
14,099
-1,473
| -9% | -$45.6K |
|
60
DuPont de Nemours
DD
$18.5B
| $387K | 0.07% |
3,003
| – | – |
|
61
GSK
GSK
$104B
| $362K | 0.06% |
7,150
+1,531
| +27% | +$76.3K |
|
62
Pfizer
PFE
$143B
| $313K | 0.05% |
11,140
-3,812
| -25% | -$109K |
|
63
Walmart Inc
WMT
$885B
| $261K | 0.04% |
+11,451
| New | +$251K |
|
64
Fortune Brands Innovations
FBIN
$5.88B
| $246K | 0.04% |
5,127
-322
| -6% | -$13.8K |
|
65
Pinnacle West Capital
PNW
$12.2B
| $236K | 0.04% |
3,145
-88
| -3% | -$6.02K |
|
66
Vanguard Short-Term Bond ETF
BSV
$44.6B
| $226K | 0.04% |
2,799
| – | – |
|
Similar funds
RIL
MC
BOH
6CM
QOP
IAN
RCAG
FTCM
Roffman Miller Associates's Q1 2016 Portfolio in Review
As of Q1 2016, Roffman Miller Associates held 66 positions worth $583M, up 6.7% from $546M the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Trading was light in Q1 2016: portfolio turnover was 3%. Roffman Miller Associates opened 2 new positions and made no exits, leaving the 66-position portfolio largely intact.
By sector, the portfolio is most concentrated in Industrials at 16% of assets, up from 16% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.
- Roffman Miller Associates's largest Q1 2016 buy was CVS Health: 73,725 shares worth $7.65M.
- Roffman Miller Associates added most to Kraft Heinz in Q1 2016, an estimated $1.48M increase.
- Roffman Miller Associates's biggest Q1 2016 reduction was Bath & Body Works, cutting an estimated $6.11M.
- Roffman Miller Associates's ten largest holdings make up 32% of its $583M portfolio in Q1 2016.
- Roffman Miller Associates opened 2 new positions and closed 0 in Q1 2016.
- Roffman Miller Associates's portfolio value rose 6.7% quarter-over-quarter to $583M.
Based on Roffman Miller Associates's 13F filing for Q1 2016, filed 9 May 2016.